PLEK2 promotes the proliferation and migration of non-small cell lung cancer cells in a BRD4-dependent manner
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PLEK2 promotes the proliferation and migration of non-small cell lung cancer cells in a BRD4-dependent manner
Authors
Keywords
-
Journal
MOLECULAR BIOLOGY REPORTS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-05
DOI
10.1007/s11033-022-07209-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BET inhibition disrupts transcription but retains enhancer-promoter contact
- (2021) Nicholas T. Crump et al. Nature Communications
- PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K/AKT signaling pathway
- (2021) Yang Liu et al. Oncology Letters
- Pleckstrin-2 is essential for erythropoiesis in β-thalassemic mice, reducing apoptosis and enhancing enucleation
- (2021) Maria Feola et al. Communications Biology
- microRNA-873 inhibits self-renewal and proliferation of pancreatic cancer stem cells through pleckstrin-2-dependent PI3K/AKT pathway
- (2021) Xiao-Li Yang et al. CELLULAR SIGNALLING
- Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes
- (2021) Hsiu-Chung Cheng et al. Translational Oncology
- BRD4 contributes to LPS-induced macrophage senescence and promotes progression of atherosclerosis-associated lipid uptake
- (2020) Hui Wang et al. Aging-US
- BRD4 levels determine the response of human lung cancer cells to BET degraders that potently induce apoptosis through suppression of Mcl-1
- (2020) Dan Zong et al. CANCER RESEARCH
- The therapeutic potential of BRD4 in cardiovascular disease
- (2020) Shigang Lin et al. HYPERTENSION RESEARCH
- Inhibition of BRD4 prevents proliferation and epithelial–mesenchymal transition in renal cell carcinoma via NLRP3 inflammasome-induced pyroptosis
- (2020) Yi-Fan Tan et al. Cell Death & Disease
- BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene
- (2020) Tatsuro Yamamoto et al. BRITISH JOURNAL OF CANCER
- Molecular Pathology of Primary Non-small Cell Lung Cancer
- (2020) David Ilan Suster et al. ARCHIVES OF MEDICAL RESEARCH
- BRD4 prevents the accumulation of R-loops and protects against transcription–replication collision events and DNA damage
- (2020) Fred C. Lam et al. Nature Communications
- Epigenetic Reader BRD4 (Bromodomain-Containing Protein 4) Governs Nucleus-Encoded Mitochondrial Transcriptome to Regulate Cardiac Function
- (2020) Soo Young Kim et al. CIRCULATION
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Very low intensity ultrasounds as a new strategy to improve selective delivery of nanoparticles-complexes in cancer cells
- (2019) Rossella Loria et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- BRD4 directs hematopoietic stem cell development and modulates macrophage inflammatory responses
- (2019) Anup Dey et al. EMBO JOURNAL
- MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation
- (2019) Sara Sdelci et al. NATURE GENETICS
- Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation
- (2019) Matthew S. Stratton et al. CIRCULATION RESEARCH
- PLEK2 mediates metastasis and vascular invasion via the ubiquitin‐dependent degradation of SHIP2 in non‐small cell lung cancer
- (2019) Dong‐ming Wu et al. INTERNATIONAL JOURNAL OF CANCER
- Current Diagnosis and Management of Small-Cell Lung Cancer
- (2019) Shuhang Wang et al. MAYO CLINIC PROCEEDINGS
- BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation
- (2019) Wen Zhu et al. BIOMEDICINE & PHARMACOTHERAPY
- BRD4 promotes tumor progression and NF-κB/CCL2-dependent tumor-associated macrophage recruitment in GIST
- (2019) Jianfeng Mu et al. Cell Death & Disease
- Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression
- (2018) Zhongyuan Gao et al. CANCER BIOLOGY & THERAPY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MKRN2 inhibits migration and invasion of non-small-cell lung cancer by negatively regulating the PI3K/Akt pathway
- (2018) Jun Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
- (2018) Ugo Testa et al. Cancers
- BRD4 and Cancer: going beyond transcriptional regulation
- (2018) Benedetta Donati et al. Molecular Cancer
- Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms
- (2017) Baobing Zhao et al. JOURNAL OF CLINICAL INVESTIGATION
- Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC
- (2016) Hanlu Yin et al. GENE
- Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors
- (2016) Utkarsh Raj et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- High level of BRD4 promotes non-small cell lung cancer progression
- (2016) Yun-Fei Liao et al. Oncotarget
- Beating the odds: BETs in disease
- (2015) Chen-Yi Wang et al. TRENDS IN BIOCHEMICAL SCIENCES
- Non-small-cell lung cancer
- (2015) Cesare Gridelli et al. Nature Reviews Disease Primers
- The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
- (2014) Junwei Shi et al. MOLECULAR CELL
- BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses
- (2013) A. C. Belkina et al. JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation